Evaluation of the Impact of the COVID-19 Pandemic on Smoking-Cessation Success Prediction in Adults

Yıl 2024, Cilt: 12 Sayı: 1, 118 - 134, 19.02.2024

Burcu Ergüden , Yasemin Aslan

https://doi.org/10.33715/inonusaglik.1378753

Öz

The aim of this study was to evaluate the impact of the COVID-19 pandemic on smoking-cessation success prediction in adult individuals who smoke. The study, designed with a quantitative cross-sectional, included individuals aged 18 and above who smoke and volunteered to participate. The "Sociodemographic and COVID-19 Information Form" and "Smoking Cessation Success Prediction Scale” were used as data collection tools. The data were collected through face-to-face interviews with the participation of 506 individuals. SPSS 26 Program and descriptive statistics were utilized in the analysis of the data. Participants who had experienced COVID-19, been hospitalized due to COVID-19, or lost a loved one due to COVID-19 and were vaccinated against COVID-19 were found to have higher smoking cessation success prediction scores. According to the study, 61.5% of the participants thought about giving up smoking as a result of COVID-19. Determining public health policies for this population, which may be at high risk for COVID-19 complications, and providing support for smoking-cessation could be beneficial.

Anahtar Kelimeler

COVID-19, Smoking-cessation, Tobacco

Proje Numarası

1919B012201355

COVID-19 PANDEMİSİNİN YETİŞKİN BİREYLERDE SİGARA BIRAKMA BAŞARI ÖNGÖRÜSÜ ÜZERİNDEKİ ETKİSİNİN DEĞERLENDİRİLMESİ

Öz

Bu çalışmanın amacı COVID-19 pandemisinin sigara kullanan yetişkin bireylerde sigara bırakma başarı öngörüsü üzerindeki etkisinin değerlendirilmesidir. Nicel yöntemle kesitsel türde tasarlanan çalışmaya 18 yaş ve üzeri, sigara kullanan ve çalışmaya katılmaya gönüllü bireyler dahil edilmiştir. Araştırmada veri toplama aracı olarak “Sosyodemografik ve COVID-19 Bilgi Formu” ile “Sigara Bırakma Başarısı Öngörü Ölçeği” kullanılmıştır. Veriler 506 kişinin katılımıyla yüz yüze görüşme tekniğiyle toplanmıştır. Verilerin analizinde SPSS 26 Programı ve tanımlayıcı istatistiklerden yararlanılmıştır. COVID-19 geçiren, COVID-19 nedeniyle hastanede yatan veya bir yakınını kaybeden, COVID-19 aşısı olan katılımcıların sigara bırakma başarısı öngörü puanlarının daha yüksek olduğu tespit edilmiştir. Katılımcıların %61.5’inin COVID-19 nedeniyle sigarayı bırakmayı düşündüğü görülmüştür. COVID-19 komplikasyonları açısından yüksek risk altında olabilecek bu popülasyona yönelik halk sağlığı politikalarının belirlenmesi ve sigaranın bırakılması yönünde destek verilmesi faydalı olabilir.

Anahtar Kelimeler

COVID-19, Sigara bırakma, Tütün

Etik Beyan

Çalışma için Bandırma Onyedi Eylül Üniversitesi Sosyal ve Beşeri Bilimler Etik Kurulunun 05.12.2022 tarih ve 2022-10 sayılı kararıyla etik kurul onayı alınmıştır.

Destekleyen Kurum

TÜBİTAK 2209-A Bilim İnsanı Destek Programları Başkanlığı (BIDEB)

Proje Numarası

1919B012201355

Teşekkür

Bu çalışmaya 1919B012201355 proje numarası ile destek veren TÜBİTAK 2209-A Bilim İnsanı Destek Programları Başkanlığı (BIDEB)’na çok teşekkür ederiz.

Kaynakça

• Adrish, M., Chilimuri, S., Mantri, N., Sun, H., Zahid, M., Gongati, S., …Singhal, R. (2020). Association of smoking status with outcomes in hospitalised patients with COVID-19. BMJ Open Respiratory Research, 7(1), e000716. https://doi.org/10.1136/bmjresp-2020-000716.
• Aydemir, Y., Doğu, Ö., Dede, C. ve Çınar, N. (2019). Sigara Bırakma Başarısı Öngörü Ölçeği: Geliştirme ve geçerlik, güvenirlik çalışması. Addicta: The Turkish Journal On Addictions, 6(2), 387-402. https://doi.org/10.15805/addicta.2019.6.2.0022.
• Baker, J., Krishnan, N., Abroms, L. C. ve Berg, C. J. (2022). The impact of tobacco use on COVID-19 outcomes: A systematic review. Journal of Smoking Cessation, 2022, 5474397. https://doi.org/10.1155/2022/5474397.
• Berlin, I., Thomas, D., Le Fauo, A. L. ve Cornuz, J. (2020). COVID 19 and smoking. Nicotine Tobacco and Research, 22(9), 1650-1652. https://doi.org/10.1093/ntr/ntaa059.
• Cai, G., Bossé, Y., Xiao, F., Kheradmand, F. ve Amos, C. I. (2020). Tobacco smoking increases the lung gene expression of ACE2, the receptor of SARS-CoV-2. American Journal of Respiratory Critical Care Medicine, 201(12), 1557-1559. https://doi.org/10.1164/rccm.202003-0693LE.
• Chang, K., Yang, S. M., Kim, S. H., Han, K. H., Park, S. J. ve Shin, J. I. (2014). Smoking and rheumatoid arthritis. International Journal of Molecular Sciences, 15(12), 22279-22295. https://doi.org/10.3390/ijms151222279.
• Çıtak, Ş. (2021). Examining the individuals’ smoking cessation success during COVID-19 based on some variables. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 10(4), 850-860. Durmaz, A. ve Yılmaz, M. (2023). The effects of being infected with COVID-19 in smokers on their smoking habits. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi, 9(2), 59-67. https://doi.org/10.30569/adiyamansaglik.1188014.
• Ebrahimi Kalan, M., Jebai, R., Li, W., Gautam, P., Alemohammad, S.Y., Mortazavizadeh, Z., …Ben Taleb, Z. (2023). COVID-19 and tobacco products use among US adults, 2021 National Health Interview Survey. Health Science Reports, 6(9), e1542. https://doi.org/10.1002/hsr2.1542. Farsalinos, K., Barboun, A. ve Niaura, R. (2020). Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: Could nicotine be a therapeutic option? International and Emergency Medicine, 15(5), 845-552. https://doi.org/10.1007/s11739-020-02355-7.
• Ferrara, P., Ponticelli, D., Agüero, F., Caci, G., Vitale, A., Borrelli, M., …Polosa, R. (2022). Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from VASCO study and need for further studies. Public Health, 203, 97-99. https://doi.org/10.1016/j.puhe.2021.12.013.
• Gaiha, S. M., Cheng, J. ve Halpern-Felsher, B. (2020). Association between youth smoking, electronic cigarette use, and COVID-19. Journal of Adolescent Health, 67(4), 519-523. https://doi.org/10.1016/j.jadohealth.2020.07.002.
• GBD 2019 Tobacco Collaborators. (2021). Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: A systematic analysis from the Global Burden of Disease Study 2019. The Lancet, 397(10292), 2337–2360. https://doi.org/10.1016/S0140-6736(21)01169-7.
• Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., …China Medical Treatment Expert Group for Covid-19. (2020). Clinical characteristics of Coronavirus disease 2019 in China. The New England Journal of Medicine, 382(18), 1708-1720. https://doi.org/10.1056/NEJMoa2002032.
• Gulland, A. (2020, Şubat 14). Smokers at increased riskof coronavirus complications, leading experts warn. 28.09.2023 tarihinde https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-dangerous-smokers/ adresinden erişildi.
• Gupta, A. K., Nethan, S. T. ve Mehrotra, R. (2021). Tobacco use as a well-recognized cause of severe COVID-19 manifestations. Respiratory Medicine, 176, 106233. https://doi.org/10.1016/j.rmed.2020.106233.
• Gülsen, A., Yigitbas, B. A., Uslu, B., Drömann, D. ve Kilinc, O. (2020). The effect of smoking on COVID-19 symptom severity: Systematic review and meta-analysis. Pulmonary Medicine, 2020, 7590207. https://doi.org/10.1155/2020/7590207.
• Günay, S., Ünsal, E., Argüder, E., Kılıç, H., Er, M., Ergüden, H. Ç., …Karalezli, A. (2021). Tütün bağımlılığının COVID-19 ağırlığı üzerine etkisi. İzmir Göğüs Hastanesi Dergisi, 35(1), 22-31. https://doi.org/10.5222/İGH.2021.53825.
• Karagöz, Y. (2014). SPSS 21.1 uygulama biyoistatistik. Ankara: Nobel Akademik Yayıncılık.
• Kayhan Tetik, B., Gedik Tekinemre, I. ve Taş, S. (2021). The efect of the COVID‑19 pandemic on smoking cessation success. Journal of Community Health, 46(3), 471-475. https://doi.org/10.1007/s10900-020-00880-2.
• Kılıç, S. (2013). Örnekleme yöntemleri. Journal of Mood Disorders, 3(1), 44-46. https://doi.org/10.5455/jmood.20130325011730.
• Krebs, N. M., D'Souza, G., Bordner, C., Allen, S. I., Hobkirk, A. L., Foulds, J. ve Yingst, J. M. (2021). COVID-19 vaccination uptake and hesitancy among current tobacco users. Tob Use Insights, 14, 1179173X211068027. https://doi.org/10.1177/1179173X211068027.
• Li, Y., Luk, T. T., Wu, Y., Cheung, D. Y. T., Li, W. H. C., Tong, H. S. C., …Wang, M. P. (2021). High perceived susceptibility to and severity of COVID-19 in smokers are associated with quitting-related behaviors. International Journal of Environmental Research and Public Health, 18(20), 10894.
• Lippi, G. ve Henry, B. M. (2020). Active smoking is not associated with severity of Coronavirus disease 2019 (COVID-19). European Journl of Internal Medicine, 75, 107-108. https://doi.org/10.1016/j.ejim.2020.03.014.
• Liu, W., Tao, Z. W., Wang, L., Yuan, M. L., Liu, K., Zhou, L., …Hu, Y. (2020). Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese Medical Journal (Engl), 133(9), 1032-1038. https://doi.org/10.1097/CM9.0000000000000775.
• Middlekauff, H. R., Park, J. ve Moheimani, R. S. (2014). Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: Mechanisms and implications for cardiovascular risk. Journal of the American College of Cardiology, 64(16), 1740-1750. https://doi.org/10.1016/j.jacc.2014.06.1201.
• Nomura, Y., Sawahata, M., Nakamura, Y., Kurihara, M., Koike, R., Katsube, O., …Sugiyama, K. (2021). Age and smoking predict antibody titres at 3 months after the second dose of the BNT162b2 COVID-19 vaccine. Vaccines, 9(9), 1042. https://doi.org/10.3390/vaccines9091042.
• Parthymou, A., Habeos, E. E., Habeos, G. I., Deligakis, A., Livieratos, E., Marangos, M. ve Chartoumpekis, D. V. (2021). SARS-CoV-2 antibody titer 3 months post-vaccination is affected by age, gender, smoking and vitamin D. medRxiv. https://doi.org/10.1101/2021.09.01.21262913.
• Patanavanich, R. ve Glantz, S. A. (2020). Smoking is associated with COVID-19 progression: A meta-analysis. Nicotine Tobacco Research, 22(9), 1653-1656. https://doi.org/10.1093/ntr/ntaa082.
• Qiu, F., Fan, P., Nie, G. D., Liu, H., Liang, C. L., Yu, W. ve Dai. Z. (2017). Effects of cigarette smoking on transplant survival: extending or shortening it? Frontiers in Immunology, 8, 127. https://doi.org/10.3389/fimmu.2017.00127.
• Sağlık Bakanlığı. (2017). Halk Sağlığı Genel Müdürlüğü, Tütün ve Madde Bağımlılığı ile Mücadele Dairesi Başkanlığı. Tütün. 10.10.2023 tarihinde https://hsgmdestek.saglik.gov.tr/tr/tutun adresinden erişildi. Sağlık Bakanlığı. (2020). COVID-19 bilgilendirme platformu, COVID19 sözlüğü. 26.06.2022 tarihinde https://covid19.saglik.gov.tr/TR-66439/c.html adresinden erişildi.
• Salah, H. M., Sharma, T. ve Mehta, J. (2020). Smoking doubles the mortality risk in COVID-19: A meta-analysis of recent reports and potential mechanisms. Cureus, 12(10), e10837. https://doi.org/10.7759/cureus.10837.
• Samet, J. M. (2020). Tobacco products and the risks of SARS-CoV-2 infection and COVID-19. Nicotine Tobacco Research, 22(1), 93-95. https://doi.org/10.1093/ntr/ntaa187.
• Sarich, P., Cabasag, C. J., Liebermann, E, Vaneckova, P., Carle, C., Hughes, S., …Soerjomataram, I. (2022). Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis. EClinicalMedicine, 47, 101375. https://doi.org/10.1016/j.eclinm.2022.101375.
• Saulyte, J., Regueira, C., Montes-Martínez, A., Khudyakov, P. ve Takkouche, B. (2014). Active or passive exposure to tobacco smoking and allergic rhinitis, allergic dermatitis, and food allergy in adults and children: A systematic review and meta-analysis. PLoS Medicine, 11(3), e1001611. https://doi.org/10.1371/journal.pmed.1001611.
• Sinha, D. N., Gupta, P. C., Kumar, A., Bhartiya, D., Agarwal, N., Sharma, S., …Mehrotra, R. (2018). The poorest of poor suffer the greatest burden from smokeless tobacco use: A study from 140 countries. Nicotine Tobacco Research, 20(12), 1529-1532. https://doi.org/10.1093/ntr/ntx276.
• Strzelak, A., Ratajczak, A., Adamiec, A. ve Feleszko, W. (2018). Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: A mechanistic review. International Journal of Environmental Research Public Health, 15(5), 1033. https://doi.org/10.3390/ijerph15051033.
• Turan, A., Eryılmaz, A. Ç., Özdener, N. ve Nacar, H. (2021, Haziran 1). COVID-19 pandemisinde telefonla sigarayı bıraktırmak fırsat. Adana İl Sağlık Müdürlüğü, Halk Sağlığı Hizmetleri Başkanlığı Yayını. COVID-19 pandemisinde telefonla sigarayı bıraktırmak fırsat. 01.10.2023 tarihinde https://adanaism.saglik.gov.tr/TR-213678/koronavirus-pandemisinde-uzaktan-sigara-birakma-destek-calismalari.html adresinden erişildi.
• Türkiye İstatistik Kurumu (TÜİK) (2023, Şubat 6). Adrese dayalı nüfus kayıt sistemi sonuçları 2022. 3 Ekim 2023 tarihinde https://data.tuik.gov.tr/Bulten/Index?p=Adrese-Dayali-Nufus-Kayit-Sistemi-Sonuclari-2022-49685 adresinden erişildi.
• U.S. Department of Health and Human Services. (2014). The health consequences of smoking: 50 years of progress, a report of the surgeon general, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Atlanta (GA): Centers for Disease Control and Prevention (US) 3 Ekim 2023 tarihinde https://www.ncbi.nlm.nih.gov/books/NBK179276/ adresinden erişildi.
• United States Environmental Protection Agency (USEPA). (2018). Secondhand tobacco smoke and smoke-free homes. 18.08.2023 tarihinde https://www.epa.gov/indoor-air-quality-iaq/secondhand-tobacco-smoke-andsmoke-free-homes adresinden adresinden erişildi.
• Umnuaypornlert, A., Kanchanasurakit, S., Lucero-Prisno, D. E. I. ve Saokaew, S. (2021). Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis. Tobacco Induced Diseases, 19, 09. https://doi.org/10.18332/tid/132411.
• Vardavas, C. ve Nikitara, K. (2020). COVID-19 and smoking: A systematic review of the evidence. Tobacco Induced Diseases, 18, 20. https://doi.org/10.18332/tid/119324.
• WHO. (2021a, July 12). Global Adult Tobacco Survey 2016, Turkey. Global Adult Tobacco Survey. 28.09.2023 tarihinde https://extranet.who.int/ncdsmicrodata/index.php/catalog/872 adresinden erişildi.
• WHO. (2021b, May 19). Quit tobacco to be a winner. 28.09.2023 tarihinde https://www.who.int/news-room/commentaries/detail/quit-tobacco-to-be-a-winner adresinden erişildi.
• WHO. (2023, July 31). Tobacco. 28.09.2023 tarihinde https://www.who.int/health-topics/tobacco#tab=tab_1 adresinden erişildi.
• WHO. (2020, Dec 8). More than 100 reasons to quit tobacco. 28.09.2023 tarihinde https://www.who.int/news-room/spotlight/more-than-100-reasons-to-quit-tobacco adresinden erişildi.
• Yazıcıoğlu, Y. ve Erdoğan, S. (2014). SPSS uygulamalı bilimsel araştırma yöntemleri. Ankara: Detay Yayıncılık.
• Zhang, J., Teng, F., Zhang, X., Wang, H., Liang, T., Guo, S. ve Yu, X. (2021). Down-regulation of SARS-CoV-2 neutralizing antibodies in vaccinated smokers. MedComm, 3(3), e166. https://doi.org/10.1002/mco2.166.